With a particular focus on CRC, we delved deeper into the expression profiles of these genes and examined their associations with clinical prognosis, biological function and the TME, and validated key genes (PHGDH, SLC1A5, SLC38A2) in real‐world CRC cohorts. This evidence concerns the gene SLC1A5 and colorectal carcinoma.